Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironori Fukuda

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Oncotarget|March 28, 2018
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomyHironori Fukuda, Toshio Takagi, Tsunenori Kondo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 9, 2022
Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives"Toshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, et al.
Urologic Oncology|April 18, 2016
Treatment-related deterioration of renal function is associated with the antitumor efficacy of sunitinib in patients with metastatic renal cell carcinomaHironori Fukuda, Tsunenori Kondo, Shoichi Iida, et al.
Journal of Robotic Surgery|July 27, 2024
Comparison of surgical outcomes of robot-assisted laparoscopic partial nephrectomy performed by a single experienced surgeon according to two reconstruction methods, including single-layer and double-layer renorrhaphyToshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, et al.
Anticancer Research|June 29, 2026
Robot-assisted Complete Urinary Tract Exenteration for Multifocal Urothelial Carcinoma: Perioperative Management in Non-dialysis PatientsKazuhiko Yoshida, Junpei Iizuka, Yuki Kobari, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 2, 2020
Nivolumab treatment beyond progression for metastatic renal cell carcinoma: New role of metastasectomy in the immune checkpoint inhibitor era?Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 18, 2022
Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinomaHiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, et al.
International Journal of Clinical Oncology|April 3, 2017
Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinomaHironori Fukuda, Tsunenori Kondo, Toshio Takagi, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2018
A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusionHironori Fukuda, Ikuma Kato, Mitsuko Furuya, et al.
Targeted Oncology|October 18, 2018
Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell CarcinomaHiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Oncotarget|March 28, 2018
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomyHironori Fukuda, Toshio Takagi, Tsunenori Kondo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 9, 2022
Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives"Toshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, et al.
Urologic Oncology|April 18, 2016
Treatment-related deterioration of renal function is associated with the antitumor efficacy of sunitinib in patients with metastatic renal cell carcinomaHironori Fukuda, Tsunenori Kondo, Shoichi Iida, et al.
Journal of Robotic Surgery|July 27, 2024
Comparison of surgical outcomes of robot-assisted laparoscopic partial nephrectomy performed by a single experienced surgeon according to two reconstruction methods, including single-layer and double-layer renorrhaphyToshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, et al.
Anticancer Research|June 29, 2026
Robot-assisted Complete Urinary Tract Exenteration for Multifocal Urothelial Carcinoma: Perioperative Management in Non-dialysis PatientsKazuhiko Yoshida, Junpei Iizuka, Yuki Kobari, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 2, 2020
Nivolumab treatment beyond progression for metastatic renal cell carcinoma: New role of metastasectomy in the immune checkpoint inhibitor era?Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 18, 2022
Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinomaHiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, et al.
International Journal of Clinical Oncology|April 3, 2017
Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinomaHironori Fukuda, Tsunenori Kondo, Toshio Takagi, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2018
A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusionHironori Fukuda, Ikuma Kato, Mitsuko Furuya, et al.
Targeted Oncology|October 18, 2018
Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell CarcinomaHiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
Pageof 13